HERON THERAPEUTICS, INC. /DE/ Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Heron Therapeutics, Inc. /De/ quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2019 to Q3 2024.
  • Heron Therapeutics, Inc. /De/ Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2024 was $160K, a 69.6% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $160K -$367K -69.6% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $233K -$403K -63.4% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $318K -$447K -58.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $416K -$487K -53.9% Dec 31, 2023 10-K 2024-03-12
Q3 2023 $527K -$529K -50.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $636K -$582K -47.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $765K -$625K -45% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $903K -$666K -42.4% Dec 31, 2022 10-K 2023-03-29
Q3 2022 $1.06M -$1.36M -56.3% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.22M -$1.48M -54.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.39M -$1.59M -53.3% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.57M -$1.7M -52.1% Dec 31, 2021 10-K 2022-02-28
Q3 2021 $2.42M -$1.17M -32.7% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $2.69M -$1.22M -31.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $2.98M -$1.27M -29.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $3.27M -$68K -2.04% Dec 31, 2020 10-K 2021-02-24
Q3 2020 $3.59M +$927K +34.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.91M +$993K +34% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $4.24M +$1.09M +34.5% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $3.34M Dec 31, 2019 10-K 2020-03-02
Q3 2019 $2.66M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.92M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $3.16M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.